Rumiantceva D G, Urumova M M, Erdes S F
Nasonova Research Institute of Rheumatology.
Ter Arkh. 2021 May 15;93(5):71517. doi: 10.26442/00403660.2021.05.200793.
The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.
现已明确，新型冠状病毒感染COVID-19（严重急性呼吸综合征冠状病毒2）会引发多种肺外并发症，包括心血管、神经和皮肤并发症，其中许多并发症在感染后数周出现或持续存在。我们报告一例临床病例，该患者在从COVID-19康复2周后首次出现强直性脊柱炎症状。根据国际和俄罗斯针对强直性脊柱炎患者管理的建议，为该患者开具了相应治疗方案，治疗效果良好，关节炎、附着点炎消失，炎性背痛减轻。
